This enzyme plays a role in the growth, migration and survival of white blood cells but is overactive. Idelalisib interferes with the growth of cancer. This page contains brief information about idelalisib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Used in combination with rituximab, [8] idelalisib is to be used in.
Idelalisib is an oral medication designed to block the action of endothelin, a natural substance in the body that narrows blood vessels. Idelalisib is used together with rituximab to treat chronic lymphocytic leukemia, and certain types of lymphoma. It works by slowing or stopping the growth of cancer cells. Idelalisib is used in combination with rituximab to treat chronic lymphocytic leukemia (cll) that has come back after other treatment.
Zydelig (idelalisib) is a prescription medicine used to treat adults with chronic lymphocytic leukemia (cll), in combination with rituxan® (rituximab), when cll comes back after prior. Idelalisib belongs to a class of drugs known as kinase inhibitors. Idelalisib is sometimes given after at. By inhibiting endothelin, idelalisib helps to relax blood.
Learn about uses, side effects, drug.
Idelalisib may cause serious (possibly fatal) liver disease.
:max_bytes(150000):strip_icc():focal(999x0:1001x2)/laci-peterson-1-1ec8518da2794e3db5d20c66793d89d4.jpg)
